Frontlight ResearchEarly access
Trial site
Instituto de Molestias Cardiovasculares de Tatui
- 5running trials
- 1closed trial
The trials here
What the 6 trials at this site are about, from their registry records.
- Conditions
- Heart failure3 trials
- Obesity3 trials
- Chronic kidney disease2 trials
- Peripheral artery disease2 trials
- Stroke2 trials
- Coronary artery disease1 trial
- Type 2 diabetes1 trial
- Phase
- Phase 35 trials
- Phase 21 trial
- Status
- Recruiting3 trials
- Active, not recruiting2 trials
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company4 trials
- Amgen2 trials
Running trials
Recruiting
Recruiting
Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Chronic kidney disease1 recruiting
- Heart failure1 recruiting
- Obesity1 recruiting
- Peripheral artery disease1 recruiting
- Stroke1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 13 Nov 2026